This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Corticosteroids are a standard first-line treatment for Duchenne muscular dystrophy, but these drugs have many sideeffects. FDA approval of Italfarmaco’s Duvyzat is the first nonsteroidal drug to pass the agency’s regulatory bar for treating this rare disease.
Could cautions about more common sideeffects soon be added to the labels of popular treatments such as Novo’s Ozempic and Lilly’s Mounjaro? On Tuesday, the FDA revealed that it is investigating patient reports of suicidal thoughts and hair loss from the use of the blood sugar-modulating products.
But these immunotherapies also come with various potentially dangerous sideeffects. | A new study examined sideeffect reports of BMCA immunotherapies from the FDA Adverse Event Reporting System, hoping to help inform doctors in their treatment decisions.
Three days after the FDA included Novo Nordisk’s semaglutide treatments Ozempic and Wegovy on a list of medicines that it would monitor for sideeffects—one of them suicide ideation—a study of medi | Three days after the FDA included Novo Nordisk’s semaglutide treatments Ozempic and Wegovy on a list of medicines that it would monitor for sideeffects—one (..)
Walk into any corporate pharma HQ, and you’re likely to see a mission statement that’s pure b t about how patients come first. Just look at any pharma product website that is nothing but a sales brochure in a majority of cases. ROI drives pharma companies. 8ight: Challenge the FDA. Want proof? 3d render ).
While GLP-1 drugs from Novo Nordisk and Eli Lilly are believed to be relatively free of serious sideeffects, a few problems have emerged as the treatments have gained wider and longer-term use.
Source: Fierce Pharma If that enthusiasm pans out in the long run, it could mean at least 300,000 patients taking the drug, or $10 billion to $15 billion in peak Aduhelm from U.S. One agency FDA adviser, resigning from his committee post in protest, called it “probably the worst drug approval decision in recent U.S.
So far in August, the FDA has announced two separate drug recalls on its website: one related to particulate concerns and the other thanks to high endotoxin levels. | So far in August, the FDA has announced two separate drug recalls on its website: one related to particulate concerns and the other thanks to high endotoxin levels.
Product websites are stagnant, and online health seekers are going elsewhere to learn about your medication’s sideeffects and cost. A website and TV commercials are not enough to get patients to ask for a prescription medication especially when fair balance lists sideeffects like cancer.
It’s time to admit that the FDA is completely out of touch regarding DTC advertising. I just finished an analysis of a pharma clients website using their analytics. For some reason, the FDA still requires fair balance on website home pages. It doesn’t happen, and the FDA should know this by now.
Apellis Pharmaceuticals' Syfovre, after achieving the first FDA approval for advanced eye disease geographic atrophy, has been associated with rare but severe sideeffects, according to the America | The American Society of Retinal Specialists sent out a note to doctors on Saturday warning of eye inflammation cases in patients who took Syfovre, (..)
In clinical trials, how many people experienced a listed sideeffect? They understand that patient content could be edited to meet FDA requirements, but they like reading others’ experiences managing their health issues. 9ine: “Why aren’t pharma websites updated?” 7even: Real patient stories.
With millions of healthcare professionals (HCPs) and patients turning to Google for medical information, paid search ads present a huge opportunity for pharma brands to boost engagement and conversions. So, how can pharma marketing teams maximize the impact of their Google Ads while staying compliant?
From promoting blockbuster drugs like Humira to leveraging new technologies, pharma marketing executives need actionable strategies to succeed in a rapidly evolving landscape. Crafting Effective Pharmaceutical Advertising Campaigns Pharmaceutical advertising thrives on delivering value.
In today’s digital-first world, Pay Per Click (PPC) advertising has become an essential strategy for pharma marketing executives. Why PPC Matters in Pharma Marketing Why invest in PPC? Example: If promoting Jardiance for diabetes management, focus on unique selling points like proven efficacy and FDA approval.
The FDA needs to study what people do when they see a DTC ad. 3hree: DTC marketing minimizes the sideeffects of prescription drugs – One of the top pages within prescription drug websites continues to be “safety information.” SUMMARY: DTC marketing is not the reason why prescription drugs cost so much.
But with strict regulations and evolving consumer expectations, how do pharma brands navigate the digital landscape effectively? Pharma professionals should take the time to research and segment their audience. Both are critical components of effective social media marketing strategies. Why It Works: People trust people.
Biogen will partner with Roche on the development, and potential sale of a promising cancer drug the Swiss pharma is advancing for several types of lymphoma, announcing Tuesday it’s exercised an option to share rights to the treatment. But is it too late for Biogen to stage a comeback with their reputation damaged?
Given that most obstructive sleep apnea patients are obese men, it’s dangerous that the sideeffects listed for Sunosi say, “tell your doctor if you have heart problems, high blood pressure, kidney problems, diabetes, or high cholesterol.” This DTC is an embaressment.
GOOD MORNING: The FDA is taking a scientific approach to evaluating direct-to-consumer (DTC) drug advertising, focusing on measuring consumer perceptions of the information presented in ads. What people seem to be interested in are drug sideeffects vs. efficacy. Since when is consumer behavior ever scientific?
But heres the challenge pharma PPC isnt like other industries. So how can pharma brands maximize their return on investment (ROI) while ensuring compliance with FDA and HIPAA regulations ? The Power of Paid Search in Pharma Instant Visibility: Organic SEO takes time. Thats where PPC advertising strategies come into play.
In today’s competitive healthcare landscape, PPC campaigns (Pay-Per-Click advertising) have emerged as a critical lever for pharma marketers aiming to deliver timely, targeted, and measurable impact. This intent-driven nature gives pharma companies a distinct advantagereaching consumers when theyre most receptive.
However, pay per click advertising (PPC) presents a powerful and targeted solution for pharma marketers looking to engage HCPs efficiently. But how can pharma marketing teams maximize the impact of PPC campaigns while ensuring compliance and generating high-value leads?
Biogen undertook a secret campaign, termed Project Onyx, to persuade FDA to approve Aduhelm. This approval was NOT about patients; it was about the profits of a pharma company in quicksand and sinking fast. That meeting was reportedly followed by a formal meeting between Biogen and FDA in June 2019.
SUMMARY: The FDA is coming under intense pressure to approve Biogen’s Alzheimer’s drug, but Aaron S. With a lot of money pouring in from MS drugs, their CEO decided that they needed to act like big pharma and moved the company to downtown Cambridge under the guise that it was necessary to get closer to biomedical R&D.
What are the sideeffects? While pharma product websites stop the train for online health seekers, the vast majority fail to provide the information needed to convince people to ask for an advertised product. The FDA can be myopic when researching how consumers view and react to DTC. That belief is out the window.
The FDA has issued a complete response letter (CRL) to Spectrum Pharma for poziotinib, its pan HER2 inhibitor for a form of lung cancer, according to South Korea’s Hanmi Pharma, which originally developed the drug. The post FDA rejects Spectrum’s lung cancer drug poziotinib appeared first on.
Advertisers want to engage audiences, but at the same time, need to adhere to updated FDA guidance released in November of 2023 for pharmaceutical ads. To help navigate this new rule, heres what pharma marketers need to know: 1. Music is a powerful force and helps elicit memory recall for commercials.
In January, amidst calls to improve patient safety by optimizing licensed drug formulations, the FDA released a draft guidance that signalled a departure from the most commonly used method of identifying a new therapy’s ideal dosage. The focus on identifying the ideal drug dosage is not new.
For pharma marketing executives and brand teams, understanding this evolution is essential to remaining competitive and compliant in a rapidly shifting healthcare environment. Pharma marketers must now meet them where they areonline and engaged. According to Pharma Marketing Network, digital transformation is not just about tools.
” According to a poll conducted last year by Gallup, people do trust pharma companies to develop life-saving medications but the “trust” in anything to do with the government has declined significantly. Whose is better at protecting us and which one has the least amount of sideeffects?
a China-based pharma company has announced it has received clearance for its Investigational New Drug (IND) application from the US Food and Drug Administration (FDA) to initiate clinical studies of T21, a 3D-printed medicine that can target specific segments in the colon to more safely deliver oral ulcerative colitis (UC) drugs.
Actinium Pharma is on course to submit its targeted radiotherapy for acute myeloid leukaemia (AML) patients needing a bone marrow transplant in the US, buoyed by top-line data from a pivotal trial.
Unsurprisingly, the US FDA has reported a noticeable increase in the number of submissions that use AI/machine learning (ML) components in recent years; in 2021, they received more than 100 submissions wherein AI use was reported.
In 2022, the FDA approved only 37 new medicines, an underwhelming number compared to 98 in 2018. Amgen buying Horizon Therapeutics and Ipsen ’s acquisition of Albireo Pharma show an increased appetite for investment in therapies for rare diseases. This was not always the case. “Up rises/second (SD 0.0628) in the placebo group.
Myovant Sciences has rejected an acquisition offer from Sumitovant Biopharma and its wholly owned subsidiary, Sumitomo Pharma. The drug won its original FDA approval in May last year to treat heavy menstrual bleeding that accompanies uterine fibroids in premenopausal women.
Ten months after ChemoCentryx scored an unexpected FDA approval for autoimmune disease therapy Tavneos, Amgen has swooped in with a $3.7 Currently, ANCA vasculitis is treated with rituximab combined with corticosteroids, which can have serious sideeffects when administered over prolonged periods.
But with strict industry regulations, pharma marketers must strike a delicate balance between performance-driven ad strategies and staying compliant with HIPAA, FDA, and GDPR guidelines. However, pharma advertising isnt as simple as traditional digital marketing. For example, a drug approved by the FDA in the U.S.
Sanofi is making a €300 million investment in Chinese biotech Innovent as part of a collaboration to bring two new cancer therapies as quickly as possible to patients in the world’s second-largest pharma market. It is being tested in a wide range of solid tumours and lymphoma, alone and in combination with other drugs.
The US Food and Drug Administration (FDA) has granted clearance to Analog Pharma and Dipharma’s abbreviated new drug application (ANDA) for 20mg nitisinone capsules. Some of the most common sideeffects of nitisinone include low platelet count, elevated tyrosine levels, eye pain, white or cloudy cornea from scarring, and pink eye.
the ads can come from different sources and that can lead to run ins with the FDA. It’s a problem pharma increasingly comes up against and one for which there is currently no singly applied solution. This second ad could be about neuropathy, one of the sideeffects of diabetes. What is the best way to solve for it?
Table of Contents Sr# Headings 1 Introduction: Why Staying Updated on Pharma News Matters 2 Emerging Trends in Pharma Marketing 3 The Role of Technology in Modern Pharma Strategies 4 Adapting to Regulatory Changes and Compliance Introduction: Why Staying Updated on Pharma News Matters In the fast-paced pharmaceutical industry, information is power.
Finch Therapeutics’s Phase III PRISM4 trial for recurrent Clostridioides difficile infection (CDI) and MaaT Pharma’s Phase III trial in steroid-resistant acute graft-versus-host disease were both put on hold. While the French MaaT Pharma has submitted further information to the FDA, its trial remains on hold. with placebo.
Food and Drug Administration (FDA) or European Medicines Agency (EMA). International sources: The focus for many labeling teams is on major sources such as FDA and EMA. Example: Top Pharma Company Using NLP to Explore Drug Label Data.
We organize all of the trending information in your field so you don't have to. Join 8,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content